Sun Pharma Share Price: US Tariff Ki Chinta Mein Stock **6%** Gira! Kya Karein?

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorKavya Nair|Published at:
Sun Pharma Share Price: US Tariff Ki Chinta Mein Stock **6%** Gira! Kya Karein?
Overview

Sun Pharma ke shares mein aaj kaafi girawat dekhi gayi, stock lagbhag **6%** neeche aa gaya. Iska reason US mein drug prices ko lekar badhti chinta hai, jiske chalte potential tariffs lag sakte hain pharma companies par.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

US Tariff Ka Darr Pharma Companies Par

Sun Pharmaceutical Industries Ltd. ke shares mein aaj 6% tak ki tezi se girawat aayi. Reports aa rahi hain ki US administration drugmakers par tariffs laga sakta hai agar woh prescription drug prices kam karne ke liye deals nahi karte. Yeh news Sun Pharma ke liye kaafi serious ho sakti hai kyunki company ka US market mein kaafi bada business hai.

Sun Pharma Ka US Market Mein Bada Exposure

Market ki yeh reaction isliye hai kyunki Sun Pharma apni total revenue ka ek bada hissa US se kamata hai. March 2025 mein khatam hue financial year mein, US sales 5.8% badhkar ₹16,200 crore ho gayi, jo company ki total revenue ka 31% banta hai. Yeh growth mostly unke specialty products ki wajah se hui hai.

Company ne innovation par bhi focus kiya hai. FY25 mein, Sun Pharma ki revenue ka 20% innovative medicines se aaya, jo FY24 mein sirf 18% tha. Illumya, Winlevi, Cequa, aur Odomzo jaise products ismein shamil hain. Iske alawa, company ne Checkpoint Therapeutics ko bhi acquire kiya hai taaki cancer treatments mein apna focus aur badha sake.

Baaki Companies Kya Kar Rahi Hain?

Badi international pharma companies jaise Pfizer Inc., AstraZeneca PLC, Johnson & Johnson, aur Merck & Co. ne already US administration ke saath deals sign kar li hain prices kam karne ke liye taaki woh tariffs se bach sakein. Yeh deals aksar US mein operations badhane ya naye platforms par commit karne ki sharten rakhti hain.

Sun Pharma Ki Apni Rai

Market mein is chinta ke bawajood, Sun Pharma ke andar se CNBC-TV18 ko pata chala hai ki company ke operations par koi bada asar padne ki umeed nahi hai. Phir bhi, company ke shares Nifty 50 index par sabse zyada girne walon mein se ek rahe, aur stock ₹1,662.6 par trade kar raha tha.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.